TNF-α, in turn, supports the formation of tertiary lymphoid structures within tumors and enhances endothelial adhesion molecule expression, facilitating the infiltration of activated T cells from the spleen into the tumor microenvironment—overcoming the “infiltration barrier” that often limits the efficacy of T cell-based therapies [26,27,28]. This evidence concerns the gene TNF and neoplasm.